Jim Shannon – 2016 Parliamentary Question to the Department of Health

The below Parliamentary question was asked by Jim Shannon on 2016-07-13.

To ask the Secretary of State for Health, what discussions he has had with his EU counterparts on co-operation on developing and making available new drugs to treat breast cancer.

Nicola Blackwood

Many new medicines in Europe, including medicines to treat breast cancer, are licensed by the European Medicines Agency (EMA). The EMA brings together scientific experts from across Europe by working closely with the national regulatory authorities, in a partnership known as the European medicines regulatory network. The Medicines and Healthcare products Regulatory Agency is an active participant in this network and its discussions.

“